贛鋒鋰業(01772.HK)由近一年低位倒升半成 首兩月多賺3倍至14億人民幣
贛鋒鋰業(01772.HK)業績快報顯示去年多賺4倍及今年首兩個月多賺3倍,該股今早隨大市低開跌至86元(守穩去年3月下旬所創52周低位85.1元),掉頭高見95元,現報94.75元,反覆回升4.9%,成交707萬股。
贛鋒2021年度業績快報顯示,按中國會計準則,去年純利按年升4.05倍至51.75億元人民幣(下同),每股收益3.66元。期內,總營收按年倍增至111.62億元;營業利潤按年升4倍至56.82億元。此外,公司今年首兩個月淨利按年升3倍至14億元,期內營收按年升2.6倍至36億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.